The inactivation of Polio-, Coxsackie- and Semliki Forest viruses by a tri-iodinated benzamido-derivative of glucose
Vanden Berghe, D.A.; Van Der Groen, G.; Pattyn, S.R.
Archives Internationales de Physiologie et de Biochimie 84(3): 670-671
1976
ISSN/ISBN: 0003-9799 PMID: 64225 Document Number: 96312
Document emailed within 1 workday
Related Documents
Bopegamage, S.A.; Petrovicová, A. 1998: Tumour necrosis factor alfa and glucose levels in sera of mice infected with coxsackie B4 and A7 viruses Acta Virologica 42(6): 409-411Scholtissek, C.; Kaluza, G. 1975: Interference with the glycosylation of Semliki Forest virus proteins Medical Biology 53(5): 357-364
Ranki, M.; Morser, J.; Glanville, N. 1975: Polysomes and initiation complexes in vitro induced by Semliki Forest virus 42S and 26S RNA Medical Biology 53(5): 395-399
Jain, C.; Madan, A.R.; Babbar, O.P. 1983: Interferon therapy in experimental Semliki forest virus disease in mice Indian Journal of Medical Research 78: 726-731
Maheshwari, R.K.; Gupta, B.M. 1973: Antiviral agents from fungi effective against Semliki Forest virus (SFV) in mice Indian Journal of Medical Research 61(9): 1292-1298
Wittek, R.; Koblet, H.; Kohler, U.; Wyler, R. 1974: Polyadenylic acid segments in the ribonucleic acids of Semliki Forest virus Pathologia et Microbiologia 41(3-4): 139-140
Krasnobaeva, Z.N.; Mel'nikova, E.E.; Gaĭdamovich, S.I. 1977: Preparation of ribonucleoproteins and virion envelopes of the Zaisan-260 and R-16225 strains of Semliki Forest virus antibody production Voprosy Virusologii 3: 336-339
Mécs, I. 1973: The kinetics of formation and sensitivity to interferon of viral intermediates appearing in chick cells infected with Semliki Forest virus Acta Virologica 17(3): 177-188
Yang, S.G.; Wo, J.E.; Li, M.W.; Yu, C.B.; Lv, G.L.; Cao, H.C.; Lu, H.F.; Wang, B.H.; Zhu, H.P.; Li, L.J. 2009: Construction and packaging of Semliki forest virus replicon particles efficiently expressing Influenza A virus (H5N1) hemagglutinin Acta Virologica 53(2): 139-141
Thompson, K.M.; Kalkowska, D.A.; Badizadegan, K. 2022: Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative Gates Open Research 6: 5
Dabrowski, J. 1975: Studies on the effect of inactivated viruses on the growth of poxvirus variolae. II. the effect of some viruses varying in heat-inactivation degree Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia 26(1): 65-79
Iavoroskaia, V.E.; Blagerman, S.K.; Gicheva, T.A. 1985: Congenital infections due to Coxsackie viruses Akusherstvo i Ginekologiia 4: 20-22
Moravcová, J.; Ledec, J.; Kopecká, D. 1973: Heart disorder due to Coxsackie viruses B Vnitrni Lekarstvi 19(7): 660-665
Cihula, J.; Horácek, J. 1978: Coxsackie viruses and diabetes mellitus Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University V Hradci Kralove 21(5): 499-506
Denys, A. 1970: Studies of the effect of guanidine hydrochloride on influenza viruses. I. Inactivation of influenza virus and some other viruses Medycyna Doswiadczalna i Mikrobiologia 22(3): 243-248
Novikov, I.I.; Stulova, M.A.; Lavrova, I.K. 1984: Myocarditis caused by Coxsackie B viruses in adults Terapevticheskii Arkhiv 56(11): 37-43
Boj, E. 1972: Pathogenesis of chronic myocarditis due to Coxsackie B 3 viruses in mice Kardiologia Polska 15(4): 397-404
Seĭbil', V.B.; Malyshkina, L.P.; Gracheva, L.A.; Kozlov, V.G. 2012: Use of the cultural variants of Coxsackie a viruses in virological practice Voprosy Virusologii 57(2): 43-46
Phadke, A.R.; Niphadkar, K.B.; Deodhare, S.G. 1971: Antibodies against Coxsackie group B viruses using HAi tests in the human sera collected from poona Journal of Postgraduate Medicine 17(3): 103-107
Lozovskaia, L.S.; Soboleva, V.D.; Dub, N.V.; Sinitsina, M.A.; Sidorova, N.S. 1983: Risk of intrauterine infection of the human fetus with Coxsackie viruses in pregnancy complicated by late toxicosis and pyelonephritis Voprosy Virusologii 28(6): 698-702